FGFR1 and neoplasm: Gremlin1 promotes tumor cell proliferation and resistance to androgen deprivation therapy (ADT) by binding to fibroblast growth factor receptor 1 (FGFR1) and activating downstream mitogen-activated protein kinase (MAPK) signaling pathways.